Patent Law in Risk Finance: When Financial Inventions Get Patented
Book: Structured Finance and Insurance: The ART of Managing Capital and Risk Author: Christopher L. Culp Publisher: Wiley Finance, 2006 ISBN: 978-0-471-70631-1
Welcome to Part Five of the book. We’ve left the theory behind and we’re now in the land of case studies and issue studies, written by guest practitioners who work in these fields every day. First up: patent law and risk finance. Not a topic you’d expect in an insurance book. But it turns out to be surprisingly important.
This chapter was written by J.B. Heaton, an attorney and PhD who specializes in litigation. His argument is straightforward: financial inventions are now patentable, people are filing patents on risk finance products, and the industry needs to pay attention.
The Founding Fathers Would Be Confused
Two hundred years ago, the idea of patenting a financial technique would have seemed absurd. Finance was commerce. Patents were for inventions and the “useful arts.” These were completely different categories.
But by the time Heaton wrote this chapter, few doubted that financial techniques were patentable subject matter. The question wasn’t whether you could patent a financial product. It was how aggressively people would enforce those patents.
Why Should Risk Finance People Care?
Patents are powerful. The owner of a US patent can exclude others from making, using, or selling the patented invention for 20 years. They can license the rights. They can sue for damages and get injunctions. For companies whose business depends on patentable technologies, patent litigation is all-out legal warfare.
And it affects customers too. If your reinsurer’s product infringes someone’s patent, that product might disappear. Or get more expensive. Or you might face liability yourself for using it.
Heaton gives several examples of financial patent fights. Columbia University patented a quasi-Monte Carlo method for pricing complex securities and people were not happy about it. The American Stock Exchange got into a legal battle with inventors who patented a process related to exchange-traded funds. Amazon famously got an injunction against Barnes & Noble over its “one-click” patent.
The Requirements for Patentability
Four conditions must be met.
Patentable subject matter. The invention has to fall into an eligible category. Books don’t qualify (that’s copyright territory). Abstract mathematical formulas don’t qualify. But processes and methods do.
Useful. The invention has to actually work. It doesn’t have to work well. Heaton jokes that a chocolate-powered car that goes 2 miles per hour might pass the usefulness test. A time machine claiming to travel to a specific date would probably be rejected as impossible.
New. The invention can’t already exist in the “prior art.” If someone published a paper describing the exact same method, it’s not new.
Nonobvious. The invention has to be something a hypothetical person with ordinary skills in the field wouldn’t think of just by looking at existing work.
The Cat Patent
Heaton uses a genuinely delightful example to illustrate these concepts: US Patent No. 5,443,036, “Method of Exercising a Cat.” Yes, really.
The patent covers using a laser pointer to make a dot of light that a cat will chase around a room for exercise. It has four claims, including one that specifies the laser dot should move at 5 to 25 feet per second.
Critics love this patent. But Heaton walks through the legal analysis and shows it’s actually hard to challenge.
Is it patentable subject matter? It’s a process, so probably yes. Is it useful? Heaton attests from personal experience that it works. Is it new? You’d need to search the prior art. Nobody published “Exercise Your Cat with a Laser Pointer” in a magazine before 1993. Is it nonobvious? This is the weakest point. The patent itself admits that cats chase reflected light. Is swapping a mirror for a laser pointer really a non-obvious leap?
The point isn’t whether this particular patent is silly. The point is that challenging even silly patents is expensive, time-consuming, and uncertain. Now imagine the stakes when the patent covers a risk transfer mechanism worth billions in annual revenue.
Real Risk Finance Patents
Heaton highlights three actual financial patents.
The Columbia University patent (No. 5,940,810) covers quasi-Monte Carlo methods for pricing securities. Anyone using low-discrepancy deterministic sequences to evaluate multidimensional integrals for security valuation by computer is potentially infringing. That’s a lot of people.
The Investors Guaranty Fund patent (No. 5,704,045) covers a system for transferring risk from risk transferors to capital providers through an entity with segregated reserves. The abstract reads like a description of insurance securitization. It has 74 claims. The company was already in litigation with Morgan Stanley over related intellectual property.
The Whitworth patent (No. 6,026,364) covers a system for replacing self-insurance with insurance using a premium financing mechanism. It has 63 claims. The inventor had a website explicitly warning that he was monitoring financial activity for potential infringement. His offer to “spend a small amount of time (at no charge) verifying whether your transaction is likely to infringe” reads more like a polite threat than a customer service offering.
Why Financial Patents Were Rare Until Recently
Three factors historically kept financial innovation out of patent territory.
Secrecy was the traditional protection method. Keep your pricing models secret. Use nondisclosure agreements. Rely on trade secret law. This worked well for proprietary quant models but left you vulnerable if someone independently invented the same thing.
First-mover advantage protected new product designs. If you launch an innovative security first, you grab market share even if competitors reverse-engineer it within a year. Tufano (1989) found that rivals imitated 35 of 58 studied financial innovations within 12 months. First-movers still captured value, but they left a lot on the table.
Legal uncertainty was the biggest factor. Most financial inventors simply didn’t believe their innovations were patentable. Courts had sent mixed signals about whether mathematical algorithms and business methods could be patented.
The State Street Decision Changed Everything
In 1998, the Court of Appeals for the Federal Circuit decided State Street Bank v. Signature Financial. This was the big one.
Signature Financial had a patent on a software system for managing a “Hub and Spoke” mutual fund pooling system. The lower court said it wasn’t patentable subject matter. The Federal Circuit reversed.
The ruling held that “the transformation of data, representing discrete dollar amounts, by a machine through a series of mathematical calculations into a final share price” was a practical application of a mathematical algorithm producing a “useful, concrete and tangible result.”
In plain English: if your mathematical formula produces a useful financial result when run on a computer, it’s patentable.
A year later in AT&T v. Excel Communications, the Federal Circuit went further. You didn’t even need a machine. The patentability question was the same regardless of the form the invention took.
And then Congress implicitly confirmed everything in 1999 by amending patent law to create a “prior use” defense specifically for business method patents. If Congress is writing defenses against business method patents, it’s accepting that business method patents are valid.
The Implications for Alternative Risk Transfer
Heaton’s conclusion is clear. Patent law is coming for the risk finance and ART industries. Hundreds of financial and insurance patent applications were in process at the Patent and Trademark Office. New patents issue with 18 months of secrecy after filing, so nobody outside the PTO knows what’s coming.
The questions that will matter most going forward are novelty and nonobviousness. Is this particular risk transfer mechanism really new? Or did someone write about it in a journal five years ago? And would a person with ordinary skills in insurance or structured finance have thought of it?
Given how incremental financial innovation tends to be, with each product building on the last in small ways, these are tough questions with expensive answers.
My Take
This chapter feels ahead of its time. Written in 2001 and included in a 2006 book, it predicted a trend that became very real. Financial patents have proliferated. The debates about whether business method patents should exist at all continue.
For risk finance professionals, the practical takeaway is simple: if you’re designing new products, check the patent landscape. And if you’ve invented something genuinely novel, consider whether patent protection makes sense for you. The days when financial innovation was a patent-free zone are over.
It’s a weird chapter to find in an insurance textbook. But it’s one of the more practical ones. Because the prettiest structured insurance program in the world is worthless if someone else holds the patent on it.
Previous: Contingent Cover Insurance Next: Weather Derivatives vs Insurance